The U.S. Food and Drug Administration on Wednesday approved selling naloxone without a prescription.The Senate is poised to vote Wednesday to repeal the 2002 measure that greenlighted the March 2003 invasion of Iraq. Russia will no longer give the U.S. advance notice about its missile tests, a senior Moscow diplomat said Wednesday.
Drugmaker Merck will soon ask health officials to authorize its experimental COVID-19 pill and the St. Thomas Office for Diversity, Equity and Inclusion addressed a visit from a TikTok personality. Reporter Luana Karl has today’s News in :90.
The U.S. moved a step closer Wednesday to offering booster doses of Pfizer’s COVID-19 vaccine to senior citizens and others at high risk from the virus as the Food and Drug Administration signed off on the targeted use of extra shots.
The U.S. gave full approval to Pfizer’s COVID-19 vaccine Monday, a milestone that could lift public confidence in the shots and spur more companies, universities and local governments to make vaccinations mandatory.
Pfizer is about to seek U.S. authorization for a third dose of its COVID-19 vaccine, saying Thursday that another shot within 12 months could dramatically boost immunity and maybe help ward off the latest worrisome coronavirus mutant.
COVID-19 vaccines finally are headed for more kids as U.S. regulators on Monday expanded use of Pfizer’s shot to those as young as 12, sparking a race to protect middle and high school students before they head back to class in the fall.
The U.S. is recommending a “pause” in using the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.
The U.S. is getting a third vaccine to prevent COVID-19, as the Food and Drug Administration on Saturday cleared a Johnson & Johnson shot that works with just one dose instead of two.
The largest vaccination campaign in U.S. history got underway Monday as health workers in select hospitals rolled up their sleeves for shots to protect them from COVID-19 and start beating back the pandemic — a day of optimism even as the nation’s death toll neared 300,000.
The U.S. gave the final go-ahead Friday to the nation’s first COVID-19 vaccine, marking what could be the beginning of the end of an outbreak that has killed nearly 300,000 Americans.
Pfizer said Monday that an early peek at the data on its coronavirus vaccine suggests the shots may be a robust 90% effective at preventing COVID-19, putting the company on track to apply later this month for emergency-use approval from the Food and Drug Administration.
This is News in :90 for Thursday, Nov. 7, 2013.
